MediSapiens

Helsinki, Finland Founded: 2009 • Age: 17 yrs
Clinical insights through Bioinformatics

About MediSapiens

MediSapiens is a Healthcare company based in Helsinki (Finland) founded in 2009. Clinical insights through Bioinformatics. MediSapiens has raised $1 million across 1 funding round from investors including Finnvera, Eqvitec Partners and VTT Ventures. MediSapiens offers products and services including Online Lottery Platform and Buku Mimpi. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery.

Company details

MediSapiens was founded in 2009 as a bioinformatics company with operations in Helsinki, Finland, and Cambridge, Massachusetts. Background in pharmaceutical research and translational genomics is leveraged to supply pharmaceutical and biomedical organizations with software platforms. These platforms are used to manage, integrate, and visualize multi-dimensional datasets, including genomic sequencing data, supporting the design of personalized drugs against life-threatening diseases.

Key Metrics
  • Total Equity Funding
    $1M (USD)

    in 1 rounds

  • Latest Funding Round
    $1M (USD), Seed

    Jun 2010

  • Investors
    Finnvera

    & 3 more

Products & Services of MediSapiens

MediSapiens offers a comprehensive portfolio of products and services, including Online Lottery Platform and Buku Mimpi.

Online Lottery Platform
Betting Service

Platform for wagering on various international lottery markets

Buku Mimpi
Prediction Tool

Feature to interpret dreams for generating lottery numbers

Funding Insights of MediSapiens

MediSapiens has successfully raised a total of $1M through 1 strategic funding round. The most recent funding activity was a Seed round of $1 million completed in June 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $1M
  • Total Rounds 1
  • Last Round Seed β€” $1M
  • First Round $1M

    (Jun 2010)

  • Investors Count 4

All 1 funding rounds of MediSapiens with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2010$1MSeed–Finnvera, Eqvitec Partners
Valuation history

4 investors in total: 4 institutional.

Investors in MediSapiens

MediSapiens has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Finnvera, Eqvitec Partners and VTT Ventures.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
eqvitec.com
vttventures.fi
Early-stage venture capital is invested in European startups across sectors.
lifelineventures.comHelsinki, Finland
Loans, investments, and financial services are provided to businesses.
1999finnvera.fiHelsinki, Finland
Premium access

Investor details for MediSapiens

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of MediSapiens

2 dated milestones of MediSapiens across 1 years, from founding to its latest funding, stage changes and deals.

  1. Founded MediSapiens is founded.
  2. Funding First funding round of $1.0M.

Web traffic of MediSapiens

Websites that share an audience with MediSapiens (medisapiens.com).

Similar websites

Websites whose visitors overlap most with MediSapiens. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
investors.fluidigm.com
investors.fluidigm.com
100%
–
neogenomics.com
61%
49K#602,029View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Medisapiens

Premium access

Complete news archive for MediSapiens

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about MediSapiens

MediSapiens was founded in 2009 and raised its 1st funding round 1 year after it was founded.

MediSapiens is headquartered in Helsinki, Finland.

MediSapiens is a funded company, having raised a total of $1M across 1 funding round to date. The company's 1st funding round was a Seed of $1M, raised on Jun 2010.

MediSapiens was founded in 2009 as a bioinformatics company with operations in Helsinki, Finland, and Cambridge, Massachusetts. Background in pharmaceutical research and translational genomics is leveraged to supply pharmaceutical and biomedical organizations with software platforms. These platforms are used to manage, integrate, and visualize multi-dimensional datasets, including genomic sequencing data, supporting the design of personalized drugs against life-threatening diseases.

MediSapiens offers Online Lottery Platform and Buku Mimpi.

MediSapiens has 4 investors. Key investors include Finnvera, Eqvitec Partners, VTT Ventures, and Lifeline Ventures.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available